supp.fit

Huperzine A: study protocols

7 study groups say how much Huperzine A participants took a day. These are the doses the studies gave. They are not a recommendation.

Huperzine A: what the research found →

Dose per serving from products

623 products in our catalogue print how much Huperzine A a serving holds.

Most common: 50 mcg to 100 mcg, 25% of 623 products.

Dose per servingProducts
5 mcg or less
5
5 mcg to 10 mcg
89
10 mcg to 25 mcg
38
25 mcg to 50 mcg
105
50 mcg to 100 mcg
157
100 mcg to 250 mcg
155
250 mcg to 500 mcg
31
500 mcg to 1 mg
1
1 mg to 2.5 mg
2
2.5 mg to 5 mg
16
over 5 mg
24

Dose per serving from research

7 study groups in 5 studies say how much Huperzine A participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 50 mcg to 100 mcg, 43% of 7 study groups.

Daily doseStudy groups
50 mcg to 100 mcg
3
100 mcg to 250 mcg
1
250 mcg to 500 mcg
2
500 mcg to 1 mg
1

Commonly used together

None of these 7 study groups took Huperzine A with anything else.

7 study groups

Study
Treatment with Huperzine A improves cognition in vascular dementia patients
2012 · Huperzine A · Patients with mild to moderate vascular dementia; age and sex not reported
200 mcg12 weeks39
[Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]
2002 · huperzine Alpha group · Adults with mild to moderate possible or probable Alzheimer disease; age and sex not reported
400 mcg12 weeks100
A phase II trial of huperzine A in mild to moderate Alzheimer disease
2011 · huperzine A 200 μg BID · Adults with mild to moderate Alzheimer disease
400 mcg16 weeks70
Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students
1999 · Hup group · Junior middle school students of unspecified age and sex, complaining of memory inadequacy
100 mcg4 weeks34
Huperzine-A in capsules and tablets for treating patients with Alzheimer disease
1999 · capsule group · Patients with Alzheimer disease
100 mcg60 days30
Huperzine-A in capsules and tablets for treating patients with Alzheimer disease
1999 · tablet group · Patients with Alzheimer disease
100 mcg60 days30
A phase II trial of huperzine A in mild to moderate Alzheimer disease
2011 · huperzine A 400 μg BID · Adults with mild to moderate Alzheimer disease
800 mcg16 weeks70